Genotype-guided Targeted Agents Plus EZH2i for Primary Refractory PTCL
Clinical trial NCT07493330 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07493330
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-23
- Primary completion
- 2029-12-12
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.